Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$807K Buy
6,300
+2,400
+62% +$283K ﹤0.01% 2304
2026
Q1
$436K Buy
3,900
+500
+15% +$62K ﹤0.01% 2626
2025
Q4
$467K Buy
+3,400
New +$483K ﹤0.01% 2150
2025
Q2
Sell
-4,100
Closed -$421K 3265
2025
Q1
$421K Sell
4,100
-21,800
-84% -$2.19M ﹤0.01% 1557
2024
Q4
$2.31M Buy
25,900
+1,000
+4% +$87.6K 0.01% 678
2024
Q3
$2.33M Buy
24,900
+20,300
+441% +$1.77M 0.01% 823
2024
Q2
$439K Buy
+4,600
New +$438K ﹤0.01% 1350
2024
Q1
Sell
-28,100
Closed -$2.62M 2841
2023
Q4
$2.62M Buy
+28,100
New +$2.98M 0.02% 537
2021
Q4
Sell
-5,500
Closed -$469K 3787
2021
Q3
$469K Buy
+5,500
New +$519K ﹤0.01% 2053

Other funds holding NTES

HRT Financial's NTES Position: Q2 2026 in Review

HRT Financial sold out of NetEase (NTES) in Q2 2026, closing a stake of 28,332 shares — an estimated $3.34M sold.

HRT Financial first reported a position in NTES in Q3 2017 and held it in 21 quarters. The position peaked at $24M in Q4 2021. 460 funds tracked by Wall St. Rank hold NTES as of Q2 2026.

  • HRT Financial reported no remaining NetEase position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 28,332 NetEase shares in Q2 2026, an estimated $3.34M.
  • HRT Financial first reported a position in NetEase in Q3 2017 and held it in 21 quarters.
  • HRT Financial's NetEase position peaked at $24M in Q4 2021.
  • 460 funds tracked by Wall St. Rank held NetEase as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.